Stay updated on Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial
Sign up to get notified when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.

Latest updates to the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows the study is no longer recruiting participants, and new help sections have been added to guide users on reading the study record and joining a study. The Intervention/Treatment header formatting was adjusted and the revision note updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check18 days agoChange DetectedThe page shows a new revision label, changing from v3.5.4 to v3.5.5. This indicates a small update to the page rather than substantive content changes.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision: v3.5.4 updated from v3.5.3, indicating a minor update to the page’s revision history. It does not modify the study details, eligibility criteria, or outcome measures.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now displays the updated system revision: v3.5.3, replacing the previous v3.5.2. This reflects a routine platform release rather than a change to study content or user-facing features.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page revision has been updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check89 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.